Impact of VEGFA and HIF1A polymorphisms on prognosis and expression changes in patients with cholangiocarcinoma
Gene Reports · 2026-12 · 45 · 102638
DOI: 10.1016/j.genrep.2026.102638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Reports, 2026-12. Verfasst von Rafael Fernandes-Ferreira und 12 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background and aims Cholangiocarcinoma (CCA) represents 15% of liver tumors worldwide. Angiogenesis, a crucial process in tumor growth, involves participation of vascular endothelial growth factor A (VEGF-A) and hypoxia-inducible factor 1-alpha (HIF-1α). We analyzed polymorphisms, gene and protein expression of VEGFA and HIF1A and its association with survival in patients with CCA. Patients and methods A total of 65 patients with CCA and 30 individuals without liver diseases were studied. Genomic DNA and total RNA were extracted for allelic discrimination and gene expression, respectively, by reverse transcription qPCR and protein expression by immunohistochemistry.
Results
Patients with HIF1A -rs11549465 polymorphism (CT genotype) showed higher expression of HIF-1α versus the wild genotype (CC; p = 0.043); while VEGFA -rs3025039 (TT) and VEGF A-rs1570360 (GG) polymorphisms were associated with shorter ( p < 0.001) and longer survival ( p = 0.011), respectively.
Conclusion
Increased expression of HIF-1α in patients with HIF1A -rs11549465 polymorphism, and VEGFA polymorphisms (rs3025039 and rs1570360) associated with shorter and longer survival, respectively, highlighting the potential of these markers for prognostic prediction.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Fernandes-Ferreira, R., Jordão, P. H. F., Calastri, M. C. J., Costa, L. B. E. D., Pereira, V. V., Abreu, A. D. S., Silva, L. A. O. D., Ferraz, M. A., Silva, R. F. D., Silva, R. D. C. M. A. D., Pinhel, M. A. D. S., Souza, D. R. S., & Boin, I. D. F. S. F. (2026). Impact of VEGFA and HIF1A polymorphisms on prognosis and expression changes in patients with cholangiocarcinoma. Gene Reports, 45, 102638. https://doi.org/10.1016/j.genrep.2026.102638
Vancouver
Fernandes-Ferreira R, Jordão PHF, Calastri MCJ, Costa LBED, Pereira VV, Abreu ADS, et al. Impact of VEGFA and HIF1A polymorphisms on prognosis and expression changes in patients with cholangiocarcinoma. Gene Reports. 2026;45:102638. doi:10.1016/j.genrep.2026.102638
BibTeX
@article{FernandesFerreira2026,
author = {Fernandes-Ferreira, Rafael and Jordão, Pedro Henrique Fogaça and Calastri, Maria Clara Jéssica and Costa, Larissa Bastos Eloy da and Pereira, Victória Vernechio and Abreu, Abner dos Santos and Silva, Lorena Alves Oliveira da and Ferraz, Marcelly Araujo and Silva, Renato Ferreira da and Silva, Rita de Cassia Martins Alves da and Pinhel, Marcela Augusta de Souza and Souza, Doroteia Rossi Silva and Boin, Ilka de Fátima Santana Ferreira},
title = {Impact of VEGFA and HIF1A polymorphisms on prognosis and expression changes in patients with cholangiocarcinoma},
journal = {Gene Reports},
year = {2026},
volume = {45},
pages = {102638},
doi = {10.1016/j.genrep.2026.102638}
}
EUVIMED